These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31400708)

  • 41. Thiophosphate and selenite conversely modulate cell death induced by glutathione depletion or cisplatin: effects related to activity and Sec contents of thioredoxin reductase.
    Peng X; Xu J; Arnér ES
    Biochem J; 2012 Oct; 447(1):167-74. PubMed ID: 22784015
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of mammalian thioredoxin reductase by black tea and its constituents: implications for anticancer actions.
    Du Y; Wu Y; Cao X; Cui W; Zhang H; Tian W; Ji M; Holmgren A; Zhong L
    Biochimie; 2009 Mar; 91(3):434-44. PubMed ID: 19059456
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protective effects of the thioredoxin and glutaredoxin systems in dopamine-induced cell death.
    Arodin L; Miranda-Vizuete A; Swoboda P; Fernandes AP
    Free Radic Biol Med; 2014 Aug; 73():328-36. PubMed ID: 24863694
    [TBL] [Abstract][Full Text] [Related]  

  • 44. To inhibit TrxR1 is to inactivate STAT3-Inhibition of TrxR1 enzymatic function by STAT3 small molecule inhibitors.
    Busker S; Page B; Arnér ESJ
    Redox Biol; 2020 Sep; 36():101646. PubMed ID: 32863208
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Noble metal targeting of thioredoxin reductase--covalent complexes with thioredoxin and thioredoxin-related protein of 14 kDa triggered by cisplatin.
    Prast-Nielsen S; Cebula M; Pader I; Arnér ES
    Free Radic Biol Med; 2010 Dec; 49(11):1765-78. PubMed ID: 20851179
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel curcumin analogue hybrids: Synthesis and anticancer activity.
    Wang JQ; Wang X; Wang Y; Tang WJ; Shi JB; Liu XH
    Eur J Med Chem; 2018 Aug; 156():493-509. PubMed ID: 30025345
    [TBL] [Abstract][Full Text] [Related]  

  • 47. TrxR1 as a potent regulator of the Nrf2-Keap1 response system.
    Cebula M; Schmidt EE; Arnér ES
    Antioxid Redox Signal; 2015 Oct; 23(10):823-53. PubMed ID: 26058897
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel mechanism of ethaselen in poorly differentiated colorectal RKO cell growth inhibition: Simultaneous regulation of TrxR transcription, expression and enzyme activity.
    Yin H; Li J; Xiong K; Wang L; Wang T; Tan Q; Fu J; Ren X; Zeng H
    Differentiation; 2011 Jan; 81(1):49-56. PubMed ID: 20864247
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synergism between thioredoxin reductase inhibitor ethaselen and sodium selenite in inhibiting proliferation and inducing death of human non-small cell lung cancer cells.
    Zheng X; Xu W; Sun R; Yin H; Dong C; Zeng H
    Chem Biol Interact; 2017 Sep; 275():74-85. PubMed ID: 28757135
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thioredoxin/thioredoxin reductase system involvement in cerebellar granule cell apoptosis.
    Bobba A; Casalino E; Petragallo VA; Atlante A
    Apoptosis; 2014 Oct; 19(10):1497-508. PubMed ID: 25055978
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A thioredoxin reductase 1 inhibitor pyrano [3,2-a] phenazine inhibits A549 cells proliferation and migration through the induction of reactive oxygen species production.
    Ding Q; Wang H; Wang Y; Lu Y
    Mol Biol Rep; 2022 Sep; 49(9):8835-8845. PubMed ID: 35780225
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatocyte Hyperproliferation upon Liver-Specific Co-disruption of Thioredoxin-1, Thioredoxin Reductase-1, and Glutathione Reductase.
    Prigge JR; Coppo L; Martin SS; Ogata F; Miller CG; Bruschwein MD; Orlicky DJ; Shearn CT; Kundert JA; Lytchier J; Herr AE; Mattsson Å; Taylor MP; Gustafsson TN; Arnér ESJ; Holmgren A; Schmidt EE
    Cell Rep; 2017 Jun; 19(13):2771-2781. PubMed ID: 28658624
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Isobavachalcone Induces ROS-Mediated Apoptosis
    Li K; Zheng Q; Chen X; Wang Y; Wang D; Wang J
    Oxid Med Cell Longev; 2018; 2018():1915828. PubMed ID: 30410640
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Osmocenyl-tamoxifen derivatives target the thioredoxin system leading to a redox imbalance in Jurkat cells.
    Scalcon V; Top S; Lee HZ; Citta A; Folda A; Bindoli A; Leong WK; Salmain M; Vessières A; Jaouen G; Rigobello MP
    J Inorg Biochem; 2016 Jul; 160():296-304. PubMed ID: 27130146
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synergistic targeting of TrxR1 and ATM/AKT pathway in human colon cancer cells.
    Shen X; Xia Y; Lu H; Zheng P; Wang J; Chen Y; Xu C; Qiu C; Zhang Y; Xiao Z; Zou P; Cui R; Ni D
    Biomed Pharmacother; 2024 May; 174():116507. PubMed ID: 38565059
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Details in the catalytic mechanism of mammalian thioredoxin reductase 1 revealed using point mutations and juglone-coupled enzyme activities.
    Xu J; Cheng Q; Arnér ES
    Free Radic Biol Med; 2016 May; 94():110-20. PubMed ID: 26898501
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sublethal concentrations of diverse gold compounds inhibit mammalian cytosolic thioredoxin reductase (TrxR1).
    Omata Y; Folan M; Shaw M; Messer RL; Lockwood PE; Hobbs D; Bouillaguet S; Sano H; Lewis JB; Wataha JC
    Toxicol In Vitro; 2006 Sep; 20(6):882-90. PubMed ID: 16510263
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression profiles of thioredoxin family proteins in human lung cancer tissue: correlation with proliferation and differentiation.
    Fernandes AP; Capitanio A; Selenius M; Brodin O; Rundlöf AK; Björnstedt M
    Histopathology; 2009 Sep; 55(3):313-20. PubMed ID: 19723146
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Brevetoxin-2, is a unique inhibitor of the C-terminal redox center of mammalian thioredoxin reductase-1.
    Chen W; Tuladhar A; Rolle S; Lai Y; Rodriguez Del Rey F; Zavala CE; Liu Y; Rein KS
    Toxicol Appl Pharmacol; 2017 Aug; 329():58-66. PubMed ID: 28551108
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Thioredoxin reductase as a novel molecular target for cancer therapy.
    Nguyen P; Awwad RT; Smart DD; Spitz DR; Gius D
    Cancer Lett; 2006 May; 236(2):164-74. PubMed ID: 15955621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.